-
Macitentan, sold
under the
brand name Opsumit, is an
endothelin receptor antagonist developed by
Actelion and
approved for the
treatment of
pulmonary arterial...
-
Macitentan/tadalafil, sold
under the
brand name Opsynvi, is a
fixed dose
combination medication used for the
treatment of
pulmonary arterial hypertension...
- both
endothelin A (ETA) and B
receptors (ETB) aprocitentan, bosentan,
macitentan,
tezosentan Selective ETA
Receptor Antagonists,
which affect endothelin...
-
include epoprostenol, treprostinil, iloprost, bosentan, ambrisentan,
macitentan, and sildenafil, tadalafil, selexipag, riociguat. Lung transplantation...
-
Ambrisentan C02KX03
Sitaxentan C02KX04
Macitentan C02KX05
Riociguat C02KX52
Ambrisentan and
tadalafil C02KX54
Macitentan and
tadalafil C02LA01
Reserpine and...
- Mp–My M-Predrol M-Zole M.V.C. 9+3 M.V.I.
mabuprofen (INN)
mabuterol (INN)
macitentan (INN)
Macrobid Macrodantin macrosalb (131 I) (INN)
macrosalb (99m tc)...
- doi:10.1177/1756287214531639. PMC 4054509. PMID 25083163. "Ppsynvi (
macitentan and tadalafil)
Becomes the
First and Only
Health Canada-Approved Once...
- in
Pennsylvania found that a
potential side
effect of
medications like
macitentan, an
endothelin receptor antagonist that is used to
treat pulmonary arterial...
- for the PAH (Pulmonary
Arterial Hypertension)
market include:
Opsumit (
Macitentan):
Actelion received approval from the FDA for the
manufacture of this...
-
potentially lethal effects in the liver.
Bosentan was a
precursor to
macitentan,
which was
approved in 2013.
Davenport AP,
Hyndman KA,
Dhaun N, Southan...
